研究業績
-
2024年01月04日In vitro detection of cellular adjuvant properties of human invariant natural killer T cells.
-
2024年01月04日In vitro differentiation of T cells: From non-human primate-induced pluripotent stem cells.
-
2024年01月04日In vitro differentiation of T cells: From CAR-modified T-iPSC.
-
2024年01月04日Differentiating CD8αβ T cells from TCR-transduced iPSCs for cancer immunotherapy.
-
2024年01月04日In vitro differentiation of T cells: From human iPS cells in feeder-free condition.
-
2024年01月04日Redifferentiation of adaptive naïve-like CTL from T-cell-derived iPSC.
-
2024年01月04日In vitro differentiation of T cells: From human embryonic stem cells and induced pluripotent stem cells.
-
2024年01月04日Junctional adhesion molecule 2 represents a subset of hematopoietic stem cells with enhanced potential for T lymphopoiesis.
-
2024年01月04日Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
-
2024年01月04日Type-I interferon delivery by iPSC-derived myeloid cells elicits antitumor immunity via XCR1+ dendritec cells.
-
2024年01月04日Developing thymus-on-a-chip and cancer-on-a-chip for cancer immunotherapy.
-
2024年01月04日iPS細胞技術を用いたがん免疫療法
